- Home
- SERA vs LNZA Comparison
SERA vs LNZA Comparison
Compare SERA & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERA | LNZA |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 77.5M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SERA | LNZA |
|---|---|---|
| Price | $2.06 | $6.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | 16.1K | ★ 46.8K |
| Earning Date | 11-12-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ 17.00 |
| Revenue | $81,000.00 | ★ $55,845,000.00 |
| Revenue This Year | $177.78 | N/A |
| Revenue Next Year | $755.56 | N/A |
| P/E Ratio | ★ N/A | $0.36 |
| Revenue Growth | 5.19 | ★ 12.61 |
| 52 Week Low | $1.56 | $5.02 |
| 52 Week High | $3.95 | $44.00 |
Technical Indicators
Market Signals| Indicator | SERA | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 52.33 |
| Support Level | $1.96 | $5.53 |
| Resistance Level | $2.07 | $6.45 |
| Average True Range (ATR) | 0.09 | 0.28 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 28.57 | 64.37 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.